Leonteq Securities AG’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-720
Closed -$8.47K 1422
2025
Q4
$8.47K Sell
720
-380
-35% -$4.1K ﹤0.01% 1210
2025
Q3
$8.49K Buy
+1,100
New +$7.71K ﹤0.01% 1120
2023
Q2
Sell
-510
Closed -$8.88K 1284
2023
Q1
$8.88K Buy
+510
New +$7.26K ﹤0.01% 1048

Other funds holding NEO

Leonteq Securities AG's NEO Position: Q1 2026 in Review

Leonteq Securities AG sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 720 shares — an estimated $8.47K sold.

Leonteq Securities AG first reported a position in NEO in Q1 2023 and held it in 3 quarters. The position peaked at $8.88K in Q1 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Leonteq Securities AG reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 720 NeoGenomics shares in Q1 2026, an estimated $8.47K.
  • Leonteq Securities AG first reported a position in NeoGenomics in Q1 2023 and held it in 3 quarters.
  • Leonteq Securities AG's NeoGenomics position peaked at $8.88K in Q1 2023.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.